Your browser doesn't support javascript.
loading
Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL Study.
Kogure, Yoshihito; Kada, Akiko; Hashimoto, Hiroya; Atagi, Shinji; Takiguchi, Yuichi; Saka, Hideo; Ebi, Noriyuki; Inoue, Akira; Kurata, Takayasu; Fujita, Yuka; Nishii, Yoichi; Itani, Hidetoshi; Endo, Takeo; Saito, Akiko M; Shibayama, Takuo; Yamamoto, Nobuyuki; Gemma, Akihiko.
Afiliación
  • Kogure Y; Department of Respiratory Medicine, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Kada A; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Hashimoto H; Core Laboratory, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Atagi S; Japan Community Health Care Organization Yamatokoriyama Hospital Health Management Center, Yamatokoriyama, Japan.
  • Takiguchi Y; Department of Medical Oncology, Chiba University Hospital, Chiba, Japan.
  • Saka H; Department of Respiratory Medicine, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Ebi N; Department of Respiratory Medicine, Fukuoka University Hospital, Fukuoka, Japan.
  • Inoue A; Department of Palliative Medicine, Tohoku University School of Medicine, Sendai, Japan.
  • Kurata T; Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan.
  • Fujita Y; Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan.
  • Nishii Y; Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan.
  • Itani H; Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, Ise, Japan.
  • Endo T; Division of Respiratory Medicine, National Hospital Organization Mito Medical Center, Mito, Japan.
  • Saito AM; Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Shibayama T; Department of Respiratory Medicine, National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Yamamoto N; Department of Pulmonary Medicine and Medical Oncology, Wakayama Medical University, Wakayama, Japan.
  • Gemma A; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.
JTO Clin Res Rep ; 4(6): 100514, 2023 Jun.
Article en En | MEDLINE | ID: mdl-37304652
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: JTO Clin Res Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: JTO Clin Res Rep Año: 2023 Tipo del documento: Article País de afiliación: Japón